Glycopeptide, method for analyzing glycopeptide, and method for analyzing cancer
Patent Information
- Application Number
- JP2025531572
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Priority Date
- 2023-07-05
- Filing Date
- 2024-07-03
- Publication Date
- 2025-01-09
AI Technical Summary
Current cancer diagnostic and therapeutic approaches targeting fibronectin, a key extracellular matrix protein, have not been translated into practical pharmaceuticals or diagnostic techniques despite decades of research, highlighting the need for novel methods to identify and analyze disease-specific epitopes, particularly in cancer.
Development of glycopeptides with specific sugar chains attached to threonine residues, which can serve as dynamic epitopes for cancer diagnosis and therapy, utilizing mass spectrometry for analysis and identification of these epitopes in serum or plasma samples.
The approach enables systematic identification of disease-specific dynamic epitopes, facilitating new diagnostic biomarkers and therapeutic antibodies, and provides a method for analyzing cancer progression by quantifying changes in glycopeptide concentrations, particularly in liver and pancreatic cancers.